Prostate Cancer: Answers To Three Key Questions About Trends In New Jersey, Recent Advances

A recent article on nj.com, titled “Prostate cancer: Answers to three key questions about trends in New Jersey, recent advances,” reveals the truth about three common prostate cancer myths. According to experts at the American Cancer Society, National Cancer Institute, and Food and Drug Administration, the majority of men diagnosed with prostate cancer do not die from the disease, the new case rate and the death rate from prostate cancer are decreasing in New Jersey, and the treatment options for prostate cancer have changed and improved over the past 10 years.

While this news is overwhelmingly positive, and although the five-year survival rate for prostate cancer is at 98.9 percent, the disease still presents many daunting challenges. Every year it claims over 26,000 lives in the US alone. Early diagnosis is difficult because there are usually no symptoms during the cancer’s early stages, and there is no definitive evidence about the best approach to screening for the condition. There is also no definitive research about whether certain lifestyle practices and medical interventions can reduce risk for the disease.

To learn more about prostate cancer, please refer to the full article, which features RCCA’s own Dr. Andrew M. Bernstein.